| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Special Articles |
Charles R. Drew University of Medicine and Science and University of California Los Angeles School of Medicine Los Angeles, California 90059
| Introduction |
|---|
|
|
|---|
Ancient Indians, Greeks, and Egyptians were aware that extracts of animal testis could promote virility, potency, and vigor in men. In modern times, the castration and testis-transplantation experiments in roosters, conducted initially by John Hunter (2) and later by Adolf Berthold (3), established the link between secretions of the testis and some of the sexually dimorphic features in the rooster. Brown- Sequard (4) recognized the association between changes in testicular function and the loss of vigor in older men; he claimed to have rejuvenated himself by injecting the extracts of guinea pig testis. In the 1930s, Butenandt (5) and Ruzicka shared the Nobel Prize for the chemical synthesis of testosterone. Although testosterone was the first hormone to be discovered and one of the first hormones to be chemically synthesized, it is ironic that we are just beginning to learn about its role in the aging process in men.
There is agreement that testosterone levels decrease with advancing age in men; however, the significance of this decrease remains unclear. We do not know whether testosterone replacement therapy in older men would have beneficial effects on muscle function, sexual function, sense of well being, and quality of life, or whether this could be done safely. There is uncertainty about the long-term effects of testosterone administration on the prostate and on the cardiovascular system. Recognizing the relative paucity of definitive data, the increasing public interest, and the controversial nature of this issue, The Journal of Clinical Endocrinology & Metabolism invited several experts to present their opinions on unresolved questions related to androgen replacement in older men. Are older men hypogonadal? How should we define hypogonadism in older men? What testosterone assay has the best discriminating ability in older men? When should free testosterone levels be measured and by what method? Can testosterone supplementation produce clinically meaningful changes in body composition and muscle function in older men? Should testosterone be given to older men with sexual dysfunction and low normal testosterone levels? What are the long-term risks of testosterone replacement in older men? How should a clinician manage an older man presenting with low testosterone levels, or with sexual dysfunction and other symptoms of hypogonadism? How should testosterone replacement be administered and monitored in older men? What are the methodological and research design problems in the conduct and interpretation of studies of testosterone replacement in older men?
It is well to remember that the debate over the relative risks and benefits of estrogen therapy in women has raged for 30 yr, and clarity has only recently begun to emerge in that field. In contrast, the debate over testosterone replacement in older men has just started; the ponderous issues of risks and benefits are unlikely to be resolved anytime soon.
| Footnotes |
|---|
Accepted May 19, 1998.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
L. Katznelson, M. W Robinson, C. L Coyle, H. Lee, and C. E Farrell Effects of modest testosterone supplementation and exercise for 12 weeks on body composition and quality of life in elderly men Eur. J. Endocrinol., December 1, 2006; 155(6): 867 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Bauman, A. M. Spungen, J. Wang, R. N. Pierson Jr., and E. Schwartz Relationship of fat mass and serum estradiol with lower extremity bone in persons with chronic spinal cord injury Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1098 - E1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wald, R. B. Meacham, L. S. Ross, and C. S. Niederberger Testosterone Replacement Therapy for Older Men J Androl, March 1, 2006; 27(2): 126 - 132. [Full Text] [PDF] |
||||
![]() |
F. Laghi, A. Antonescu-Turcu, E. Collins, J. Segal, D. E. Tobin, A. Jubran, and M. J. Tobin Hypogonadism in Men with Chronic Obstructive Pulmonary Disease: Prevalence and Quality of Life Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 728 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Laghi, W. E. Langbein, A. Antonescu-Turcu, A. Jubran, C. Bammert, and M. J. Tobin Respiratory and Skeletal Muscles in Hypogonadal Men with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 598 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Schmidt, K. L. Berlin, M. A. Danaceau, A. Neeren, N. A. Haq, C. A. Roca, and D. R. Rubinow The Effects of Pharmacologically Induced Hypogonadism on Mood in Healthy Men Arch Gen Psychiatry, October 1, 2004; 61(10): 997 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Korbonits, M. Slawik, D. Cullen, R. J. Ross, G. Stalla, H. Schneider, M. Reincke, P. M. Bouloux, and A. B. Grossman A Comparison of a Novel Testosterone Bioadhesive Buccal System, Striant, with a Testosterone Adhesive Patch in Hypogonadal Males J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2039 - 2043. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Tremblay, J. L. Copeland, and W. Van Helder Effect of training status and exercise mode on endogenous steroid hormones in men J Appl Physiol, February 1, 2004; 96(2): 531 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Muller, Y. T. van der Schouw, J. H. H. Thijssen, and D. E. Grobbee Endogenous Sex Hormones and Cardiovascular Disease in Men J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5076 - 5086. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Creutzberg, E. F. M. Wouters, R. Mostert, R. J. Pluymers, and A. M. W. J. Schols A Role for Anabolic Steroids in the Rehabilitation of Patients With COPD?: A Double-Blind, Placebo-Controlled, Randomized Trial Chest, November 1, 2003; 124(5): 1733 - 1742. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Callies, H. Stromer, R. H. G. Schwinger, B. Bolck, K. Hu, S. Frantz, A. Leupold, S. Beer, B. Allolio, and A. W. Bonz Administration of Testosterone Is Associated with a Reduced Susceptibility to Myocardial Ischemia Endocrinology, October 1, 2003; 144(10): 4478 - 4483. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kinniburgh, H. Zhu, L. Cheng, A.T. Kicman, D.T. Baird, and R.A. Anderson Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men Hum. Reprod., June 1, 2002; 17(6): 1490 - 1501. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Singh, S. Hsia, P. Alaupovic, I. Sinha-Hikim, L. Woodhouse, T. A. Buchanan, R. Shen, R. Bross, N. Berman, and S. Bhasin The Effects of Varying Doses of T on Insulin Sensitivity, Plasma Lipids, Apolipoproteins, and C-Reactive Protein in Healthy Young Men J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 136 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vermeulen Androgen Replacement Therapy in the Aging Male--A Critical Evaluation J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2380 - 2390. [Full Text] [PDF] |
||||
![]() |
H. C. Margolese The Male Menopause and Mood: Testosterone Decline and Depression in the Aging Male--Is There a Link? J Geriatr Psychiatry Neurol, July 1, 2000; 13(2): 93 - 101. [Abstract] [PDF] |
||||
![]() |
E. Barrett-Connor, J. E. Mueller, D. G. von Mühlen, G. A. Laughlin, D. L. Schneider, and D. J. Sartoris Low Levels of Estradiol Are Associated with Vertebral Fractures in Older Men, But Not Women: The Rancho Bernardo Study J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 219 - 223. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |